A business in context

INTS research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-11 · 0001567264-26-000061 · Items 2.02,9.01

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001567264-26-000059

  3. 4 · Ownership change

    Report date 2026-07-16 · 0001934188-26-000002

  4. 4 · Ownership change

    Report date 2026-07-16 · 0001895944-26-000008

  5. 4 · Ownership change

    Report date 2026-07-16 · 0001875180-26-000002

  6. 4 · Ownership change

    Report date 2026-07-16 · 0001524547-26-000009

  7. 4 · Ownership change

    Report date 2026-07-16 · 0001278042-26-000002

  8. 4 · Ownership change

    Report date 2026-07-16 · 0001238705-26-000007

  9. 4 · Ownership change

    Report date 2026-07-16 · 0001231945-26-000002

  10. 4 · Ownership change

    Report date 2026-06-30 · 0001895944-26-000006

  11. 8-K · Current report

    Report date 2026-06-16 · 0001567264-26-000049 · Items 5.07

  12. 8-K · Current report

    Report date 2026-05-07 · 0001567264-26-000047 · Items 2.02,9.01

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001567264-26-000046

  14. DEF 14A · Proxy statement

    Report date 2026-04-30 · 0001567264-26-000035

  15. 8-K · Current report

    Report date 2026-03-27 · 0001567264-26-000025 · Items 2.02,9.01

  16. 10-K · Annual report

    Report date 2025-12-31 · 0001567264-26-000024

  17. 8-K · Current report

    Report date 2026-03-23 · 0001567264-26-000021 · Items 8.01,9.01

  18. 8-K · Current report

    Report date 2026-03-05 · 0001567264-26-000014 · Items 8.01,9.01

  19. 8-K · Current report

    Report date 2026-03-05 · 0001567264-26-000011 · Items 2.02,9.01

  20. 8-K · Current report

    Report date 2026-02-13 · 0001567264-26-000007 · Items 3.03,5.03,8.01,9.01

  21. 8-K · Current report

    Report date 2025-12-04 · 0001567264-25-000111 · Items 3.01,9.01

  22. 8-K · Current report

    Report date 2025-12-04 · 0001567264-25-000109 · Items 8.01,9.01

  23. 8-K · Current report

    Report date 2025-11-06 · 0001567264-25-000104 · Items 2.02,9.01

  24. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001567264-25-000103

  25. 8-K · Current report

    Report date 2025-10-30 · 0001628280-25-047855 · Items 1.01,8.01,9.01

  26. 8-K · Current report

    Report date 2025-10-22 · 0001567264-25-000096 · Items 5.07

  27. 8-K · Current report

    Report date 2025-09-10 · 0001567264-25-000093 · Items 8.01

  28. DEF 14A · Proxy statement

    Report date 2025-09-09 · 0001567264-25-000090

  29. 8-K · Current report

    Report date 2025-08-08 · 0001567264-25-000081 · Items 5.03,8.01,9.01

  30. 8-K · Current report

    Report date 2025-08-07 · 0001567264-25-000078 · Items 2.02,9.01

  31. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001567264-25-000077

  32. 8-K · Current report

    Report date 2025-08-04 · 0001567264-25-000071 · Items 8.01,9.01

  33. 8-K · Current report

    Report date 2025-07-17 · 0001567264-25-000069 · Items 5.07

  34. 8-K · Current report

    Report date 2025-06-11 · 0001628280-25-031311 · Items 1.01,3.02,8.01,9.01

  35. 8-K · Current report

    Report date 2025-06-06 · 0001567264-25-000056 · Items 3.01

  36. DEF 14A · Proxy statement

    Report date 2025-06-02 · 0001567264-25-000050

  37. 8-K · Current report

    Report date 2025-05-19 · 0001567264-25-000042 · Items 3.01

  38. 8-K · Current report

    Report date 2025-05-13 · 0001567264-25-000040 · Items 2.02,9.01

  39. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001567264-25-000039

  40. 8-K · Current report

    Report date 2025-04-24 · 0001628280-25-020057 · Items 1.01,8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 9 transaction rows9AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

9 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-07-16
2026-07-20
Donovan DanielA · Grant / award
Acquired
Stock Option (right to buy Common Stock)
Derivative security
5500.00.0
2026-07-16
2026-07-20
Wesolowski John MA · Grant / award
Acquired
Stock Option (right to buy Common Stock)
Derivative security
11000.00.0
2026-07-16
2026-07-20
Leahy EmerA · Grant / award
Acquired
Stock Option (right to buy Common Stock)
Derivative security
5500.00.0
2026-07-16
2026-07-20
Talamo JosephA · Grant / award
Acquired
Stock Option (right to buy Common Stock)
Derivative security
34000.00.0
2026-07-16
2026-07-20
GOLDBERG MARK AA · Grant / award
Acquired
Stock Option (right to buy Common Stock)
Derivative security
5500.00.0
2026-07-16
2026-07-20
BENDER LEWIS HA · Grant / award
Acquired
Stock Option (right to buy Common Stock)
Derivative security
78000.00.0
2026-07-16
2026-07-20
DUBIN THOMAS I HA · Grant / award
Acquired
Stock Option (right to buy Common Stock)
Derivative security
5500.00.0
2026-06-30
2026-07-01
Wesolowski John MA · Grant / award
Acquired
Common Stock, $0.0001 Par Value3688.03.49
2026-06-30
2026-07-01
Talamo JosephA · Grant / award
Acquired
Common Stock, $0.0001 Par Value1093.03.49

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001567264INTENSITY THERAPEUTICS, INC.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

    Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

    Explore the CPI history ↗